Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 6/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.53 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.53 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.53 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | DRD1 | P21728 | 1/20 | 0.53 |
| ▸ | HRH2 | P25021 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 1/20 | 0.53 |
| ▸ | HTR2C | P28335 | 1/20 | 0.53 |
| ▸ | HRH1 | P35367 | 1/20 | 0.53 |
| ▸ | DRD3 | P35462 | 1/20 | 0.53 |
| ▸ | SCN1A | P35498 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isomylamine SCHEMBL121991 | 0.99 | CYP3A4 (0.54) | CHRM2CHRM1CYP3A4SIGMAR1LMNA | |
| SCHEMBL16144365 | 0.81 | CHRM2 (0.53) | CHRM2CHRM1CYP3A4SIGMAR1LMNA | |
| SCHEMBL11919608 | 0.76 | MAPK1 (0.40) | LMNAMEN1KMT2AMAPK1ALDH1A1 | |
| SCHEMBL28784906 | 0.73 | CYP4F2 (0.48) | LMNAALDH1A1 | |
| SCHEMBL2940467 | 0.73 | CYP4F2 (0.57) | CYP2D6NPSR1 | |
| SCHEMBL3316687 | 0.70 | CYP4F2 (0.54) | CHRM2CHRM1CYP3A4SIGMAR1LMNA | |
| SCHEMBL28233707 | 0.70 | CYP4F2 (0.41) | CHRM2CHRM1CYP3A4SIGMAR1LMNA | |
| Dicyclomine SCHEMBL3317 | 0.69 | CYP3A4 (1.00) | CHRM2CHRM1CYP3A4SIGMAR1LMNA | |
| SCHEMBL16344762 | 0.69 | CTSL (0.45) | ALDH1A1 | |
| SCHEMBL5520693 | 0.69 | CYP2C19 (0.50) | CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119182395-A | Universal counting method and device for incremental encoder based on programmable logic unit, electronic equipment and storage medium | 中国铁建重工集团股份有限公司 | 2024-12-24 | — | — | CN | claimed |
| CN-118502717-B | Arithmetic logic unit, processor, computing chip, and computing device | 深圳比特微电子科技有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-118502717-A | Arithmetic logic unit, processor, computing chip, and computing device | 深圳比特微电子科技有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-112544571-B | Establishment and application of caenorhabditis elegans model for evaluating safety and efficacy of sun-screening agent | 上海应用技术大学 | 2023-03-03 | — | — | CN | claimed |
| CN-115703715-A | Central control and finished product analysis method for sunscreen agent A-Plus | 马鞍山科思化学有限公司 | 2023-02-17 | — | — | CN | claimed |
| CN-113300057-B | Lug dislocation adjusting method and system | 广东利元亨智能装备股份有限公司 | 2022-10-25 | — | — | CN | claimed |
| CN-112752447-B | Manufacturing process of circuit board with embedded components | 惠州市大亚湾科翔科技电路板有限公司 | 2022-05-17 | — | — | CN | claimed |
| WO-2026104762-A1 | NUCLEIC ACID VACCINE AGAINST TUBERCULOSIS | TAMPERE UNIVERSITY FOUNDATION SR (FI) | 2026-05-21 | — | — | WO | disclosed |
| CN-116984040-B | Dry bipolar electrochemiluminescence micro-fluidic chip and application thereof in protein and nucleic acid detection | 华南师范大学 | 2026-05-12 | — | — | CN | disclosed |
| EP-4724029-A1 | LOW PENETRATION SUNSCREEN COMPOSITIONS | Kenvue Brands LLC (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4721752-A2 | HERSTELLUNG UND VERWENDUNG VON IN VITRO-SYNTHETISIERTER SSRNA ZUR EINFÜHRUNG IN SÄUGETIERZELLEN ZUR INDUKTION EINER BIOLOGISCHEN ODER BIOCHEMISCHEN WIRKUNG | CELLSCRIPT, LLC (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20260014276-A1 | AN OPTOGENETIC GENE THERAPY FOR TREATING BLINDNESS | CORNELL UNIVERSITY (US) | 2026-01-15 | — | — | US | disclosed |
| EP-4676591-A2 | SMALL MOLECULE FSH RECEPTOR MODULATORS | Ferring B.V. (NL) | 2026-01-14 | — | — | EP | disclosed |
| EP-0791238-A4 | LIQUID DISTRIBUTION SYSTEM | SARNOFF DAVID RES CENTER (US) | 1998-09-02 | — | — | EP | disclosed |
| WO-1997044063-A2 | DHA-PHARMACEUTICAL AGENT CONJUGATES | NEUROMEDICA, INC. (US) | 1997-11-27 | — | — | WO | disclosed |
| EP-0791238-A1 | LIQUID DISTRIBUTION SYSTEM | Sarnoff Corporation (US) | 1997-08-27 | — | — | EP | disclosed |
| WO-1996039252-A1 | ELECTROKINETIC PUMPING | DAVID SARNOFF RESEARCH CENTER, INC. (US) | 1996-12-12 | — | — | WO | disclosed |
| WO-1996015576-A9 | LIQUID DISTRIBUTION SYSTEM | — | 1996-08-29 | — | — | WO | disclosed |
| WO-1996015576-A1 | LIQUID DISTRIBUTION SYSTEM | DAVID SARNOFF RESEARCH CENTER, INC. (US) | 1996-05-23 | — | — | WO | disclosed |
| US-4673754-A | Platinum and palladium complexes | INCO ALLOYS INTERNATIONAL, INC. (US) | 1987-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014276-A1 | AN OPTOGENETIC GENE THERAPY FOR TREATING BLINDNESS | CRY2, NR2E3, PER2 | CHRM2 1091/4885CHRM1 2155/4885CYP3A4 4866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.